Your browser doesn't support javascript.
loading
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.
Gottlieb, David J; Sutrave, Gaurav; Jiang, Wei; Avdic, Selmir; Street, Janine A; Simms, Renee; Clancy, Leighton E; Antonenas, Vicki; Gloss, Brian S; Bateman, Caroline; Bishop, David C; Micklethwaite, Kenneth P; Blyth, Emily.
Afiliación
  • Gottlieb DJ; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, New South Wales.
  • Sutrave G; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales.
  • Jiang W; Department of Haematology, Westmead Hospital, Sydney, New South Wales.
  • Avdic S; T-Cell Therapies Group, Westmead Institute for Medical Research, Sydney, New South Wales.
  • Street JA; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, New South Wales.
  • Simms R; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales.
  • Clancy LE; T-Cell Therapies Group, Westmead Institute for Medical Research, Sydney, New South Wales.
  • Antonenas V; Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, New South Wales.
  • Gloss BS; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales.
  • Bateman C; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales.
  • Bishop DC; T-Cell Therapies Group, Westmead Institute for Medical Research, Sydney, New South Wales.
  • Micklethwaite KP; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales.
  • Blyth E; T-Cell Therapies Group, Westmead Institute for Medical Research, Sydney, New South Wales.
Am J Hematol ; 98(1): 159-165, 2023 01.
Article en En | MEDLINE | ID: mdl-35560045

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Infecciones por Virus de Epstein-Barr / Leucemia-Linfoma Linfoblástico de Células Precursoras / Enfermedad Injerto contra Huésped Límite: Humans Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Infecciones por Virus de Epstein-Barr / Leucemia-Linfoma Linfoblástico de Células Precursoras / Enfermedad Injerto contra Huésped Límite: Humans Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article